Triobio Pharmaceutical Private Limited
About Triobio Pharmaceutical Private Limited
Data last updated:
Triobio Pharmaceutical Private Limited is a private limited company based in Aligarh, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85320UP2017PTC096463.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anuj Pratap Singh and Kamlesh Kumari.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at H.No. 132 B 23 Shriram Puram Colony Melrose Bye Pass Road Koil, Aligarh, Uttar Pradesh, India – 202001.
As per the financials filed for FY 2019, the company reported a revenue of ₹10,000. For the same year it recorded a net loss of ₹49,714 (net margin -497.1%) and EBITDA of -₹49,714 (EBITDA margin -497.1%).
As per MCA filings, the company has open charges of ₹45 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No. 132 B 23 Shriram Puram Colony Melrose Bye Pass Road Koil, Aligarh, Uttar Pradesh, India – 202001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Triobio Pharmaceutical Private Limited
The main business activity of Triobio Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Triobio Pharmaceutical Private Limited FY 2019 filings available
Triobio Pharmaceutical Private Limited reported revenue of ₹10,000 for FY 2019.
Financial Statement Summary of Triobio Pharmaceutical Private Limited
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹49,714 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹49,714 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Triobio Pharmaceutical Private Limited
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -497.1% | •••• |
| Net Profit Margin | -497.1% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Triobio Pharmaceutical are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Triobio Pharmaceutical Private Limited
Triobio Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Triobio Pharmaceutical Private Limited this company | ₹10,000 (FY 2019) | •••• | •••• | •••• | Aligarh, Uttar Pradesh, India | |
| Sora Trades Private Limited | ₹10,000 (FY 2023) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Shansha Marketing Private Limited | ₹10,000 (FY 2022) | •••• | •••• | •••• | Bijnor, Uttar Pradesh, India | |
| Outfiels Agencies Private Limited | ₹10,000 (FY 2024) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Cadlac Pharmaceuticals Private Limited | ₹10,000 (FY 2025) | •••• | •••• | -96.0% | •••• | Meerut, Uttar Pradesh, India |
| VCM Technologies Private Limited | ₹10,000 (FY 2024) | •••• | •••• | •••• | Guntur, Andhra Pradesh, India | |
| Sinai Communications Private Limited | ₹10,000 (FY 2024) | •••• | •••• | •••• | Delhi, India | |
| Arion Vyapar Private Limited | ₹10,000 (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Narayana Agri Solution Private Limited | ₹10,000 (FY 2021) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Top Rich Food Enterprises India Private Limited | ₹10,000 (FY 2024) | •••• | •••• | -47.0% | •••• | Hyderabad, Telangana, India |
| Sreshta Consumer Products Private Limited | ₹10,000 (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Triobio Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Triobio Pharmaceutical Private Limited
Triobio Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuj Pratap Singh | Director | 30 Aug 2017 | 9 Years 1 Months | Current |
| Kamlesh Kumari | Director | 24 Dec 2018 | 7 Years 9 Months | Current |
Charges & Borrowings of Triobio Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2019 | Others | ₹45 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Triobio Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Triobio Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Triobio Pharmaceutical Private Limited
Triobio Pharmaceutical Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Kamlesh Kumari was appointed as Director on 24 Dec 2018.
Credit Ratings, Litigation & Regulatory Alerts for Triobio Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Triobio Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Triobio Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Triobio Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Triobio Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Triobio Pharmaceutical Private Limited
Triobio Pharmaceutical is an active private limited company based in Aligarh, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 August 2017 (9+ years old) and is registered under CIN U85320UP2017PTC096463.
Triobio Pharmaceutical reported revenue of ₹10,000 for FY 2019.
Triobio Pharmaceutical has 2 current directors:
- Anuj Pratap Singh - Director
- Kamlesh Kumari - Director
Triobio Pharmaceutical reported a net loss of ₹49,714 (net margin -497.1%) and EBITDA of -₹49,714 (EBITDA margin -497.1%) for FY 2019, as per its filed financial statements.
The CIN (Corporate Identification Number) of Triobio Pharmaceutical is U85320UP2017PTC096463. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Triobio Pharmaceutical was incorporated on 30 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Triobio Pharmaceutical by revenue are Sora Trades Private Limited, Shansha Marketing Private Limited, Outfiels Agencies Private Limited, Cadlac Pharmaceuticals Private Limited, VCM Technologies Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Kamlesh Kumari was appointed as Director on 24 Dec 2018. Ravi Raj Singh ceased to be Director on 24 Dec 2018. Himanshu ceased to be Director on 02 Jan 2018. Triobio Pharmaceutical has 4 board changes on record in total.
The registered office of Triobio Pharmaceutical is at H.No. 132 B 23 Shriram Puram Colony Melrose Bye Pass Road Koil, Aligarh, Uttar Pradesh, India – 202001.
Triobio Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Triobio Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.